Omeros (OMER) FCF Margin Growth (5y) (2015 - 2026)
Omeros (OMER) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,456.00 |
| Jun 30, 2022 | -14,373.00 |
| Mar 31, 2022 | -11,295.00 |
| Dec 31, 2021 | 10,744.00 |
| Sep 30, 2021 | 2,056.00 |
| Jun 30, 2021 | 3,220.00 |
| Mar 31, 2021 | 3,294.00 |
| Dec 31, 2020 | 7,635.00 |
| Sep 30, 2020 | 31,578.00 |
| Jun 30, 2020 | 24,377.00 |
| Mar 31, 2020 | 446,501.00 |
| Dec 31, 2019 | 865,719.00 |
| Sep 30, 2019 | 742,888.00 |
| Jun 30, 2019 | 3.39 Mn |
| Mar 31, 2019 | 1.11 Mn |
| Dec 31, 2018 | 10,238.00 |
| Sep 30, 2018 | 485,400.00 |
| Jun 30, 2018 | 483,006.00 |
| Mar 31, 2018 | 10,417.00 |
| Dec 31, 2017 | 80,297.00 |